U.S. Electrophysiology Mapping and Ablation Device Market Will Grow at a 10 Percent Compound Annual Growth Rate through 2022: Updated Guidelines and Launch of Contact Force-Sensing Catheters Will Drive Continued Interest in Treating Atrial Fibrillation, According to Findings from Decision Resources Group

BURLINGTON, Mass., June 18, 2014 /PRNewswire/ -- Decision Resources Group finds that the U.S. electrophysiology (EP) mapping and ablation device market will continue to experience strong growth through 2022 as a result of the increasing adoption of catheter ablation as a treatment for atrial fibrillation (AF). The continued uptake of ablation in this indication will drive the market at a strong 10 percent compound annual growth rate through 2022.

Other key findings from Decision Resources Group's coverage of the U.S. EP mapping and ablation device market:

Updated U.S. guidelines: Although the trend toward treating AF with ablation has been ongoing for the past few years, the 2014 update to U.S. guidelines just elevated the status of catheter ablation to a...